Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3134419
Max Phase: Preclinical
Molecular Formula: C19H20O7
Molecular Weight: 360.36
Molecule Type: Small molecule
Associated Items:
ID: ALA3134419
Max Phase: Preclinical
Molecular Formula: C19H20O7
Molecular Weight: 360.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCc1cc(O)cc(O)c1C(=O)Oc1ccc(C(=O)O)c(O)c1
Standard InChI: InChI=1S/C19H20O7/c1-2-3-4-5-11-8-12(20)9-16(22)17(11)19(25)26-13-6-7-14(18(23)24)15(21)10-13/h6-10,20-22H,2-5H2,1H3,(H,23,24)
Standard InChI Key: JKUMUJVMZAUXGF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 360.36 | Molecular Weight (Monoisotopic): 360.1209 | AlogP: 3.45 | #Rotatable Bonds: 7 |
Polar Surface Area: 124.29 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.95 | CX Basic pKa: | CX LogP: 5.97 | CX LogD: 2.47 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.34 | Np Likeness Score: 0.81 |
1. Lin H, Annamalai T, Bansod P, Tse-Dinh YC, Sun D.. (2013) Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors., 4 (12): [PMID:24363888] [10.1039/c3md00238a] |
Source(1):